TY - BOOK
T1 - Targeted therapy for solid tumors and hematologic malignancies
AU - Quintas-Cardama, Alfonso
AU - Gibbons, Don L.
AU - Cataldo, Vince
N1 - Publisher Copyright:
© 2011 by Nova Science Publishers, Inc. All rights reserved.
PY - 2011/1/1
Y1 - 2011/1/1
N2 - Endocrine malignancies are rare tumors that are derived from endocrine cells located throughout the body. They encompass a heterogeneous group of malignancies, derived from different endocrine and neuroendocrine cells and have different clinically. The majority of endocrine neoplasms are benign, where the potential for invasion or metastasis is very low. Nevertheless, there is a group of endocrine neoplasms with malignant potential, and thus come under the management of medical oncology, often requiring systemic therapy. These include neuroendocrine tumors, anaplastic and medullary thyroid carcinomas, pheochromocytomas or paragangliomas, and adrenocortical carcinomas. While surgery continues to play a seminal role, the management of advanced endocrine neoplasia is more complex due to their rarity and heterogeneity. This book discusses the use of targeted therapy in the treatment of solid tumors and hematologic malignancies.
AB - Endocrine malignancies are rare tumors that are derived from endocrine cells located throughout the body. They encompass a heterogeneous group of malignancies, derived from different endocrine and neuroendocrine cells and have different clinically. The majority of endocrine neoplasms are benign, where the potential for invasion or metastasis is very low. Nevertheless, there is a group of endocrine neoplasms with malignant potential, and thus come under the management of medical oncology, often requiring systemic therapy. These include neuroendocrine tumors, anaplastic and medullary thyroid carcinomas, pheochromocytomas or paragangliomas, and adrenocortical carcinomas. While surgery continues to play a seminal role, the management of advanced endocrine neoplasia is more complex due to their rarity and heterogeneity. This book discusses the use of targeted therapy in the treatment of solid tumors and hematologic malignancies.
UR - http://www.scopus.com/inward/record.url?scp=85029958766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029958766&partnerID=8YFLogxK
M3 - Book
AN - SCOPUS:85029958766
SN - 9781617618543
BT - Targeted therapy for solid tumors and hematologic malignancies
PB - Nova Science Publishers, Inc.
ER -